The effects of antilymphocytic serum (ALS) on Trypanosoma lewisi infection.
D000372:Agglutination Tests; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology / Q000627:therapeutic use*; D002455:Cell Division; D005260:Female; D006400:Hematocrit; D007165:Immunosuppression Therapy; D008198:Lymph Nodes; D008214:Lymphocytes; D008643:Mesentery; D008722:Methods; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen; D013997:Time Factors; D014350:Trypanosoma lewisi / Q000276:immunology*; D014352:Trypanosomiasis / Q000188:drug therapy / Q000276:immunology*
D000961:Antilymphocyte Serum